Clinical Trial Update: Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating a combination of adoptive T cell therapy, dendritic cell vaccines, and hematopoietic stem cells …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Drugs mentioned

• Adoptive T Cell Therapy
• Dendritic Cell Vaccines
• Hematopoietic Stem Cell Therapy
• Immune Checkpoint Blockade (immune checkpoint inhibitor)

Snippet

Sponsor: University of Florida | Conditions: Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING